ORIGINAL RESEARCH
Accepted on 24 Nov 2025
Activation of the STING pathway potentiates the antitumor efficacy of doxorubicin in soft-tissue sarcoma
- 150 views
- Frontiers in Pharmacology
- Pharmacology of Anti-Cancer Drugs
- Research Topics
- Combination Therapies in Cancer Treatment: Enhancing Efficacy and Reducing Resistance
Combination Therapies in Cancer Treatment: Enhancing Efficacy and Reducing Resistance
11k
Total downloads
60k
Total views and downloads
Articles
ORIGINAL RESEARCH
Published on 31 Oct 2025
Chemosensitizing effect of apigenin on T-ALL cell therapy
doi 10.3389/fphar.2025.1631505
- 1,453 views
REVIEW
Published on 17 Oct 2025
Clinically approved immunotoxins targeting hematological cancers: “the best of both worlds”
doi 10.3389/fphar.2025.1569502
- 1,295 views
ORIGINAL RESEARCH
Published on 15 Sep 2025
Phytochemical combinations of lichen Evernia prunastri (L.) Ach. reduce drug resistance to temozolomide but not to paclitaxel in vitro
doi 10.3389/fphar.2025.1633978
- 1,310 views
ORIGINAL RESEARCH
Published on 23 Jul 2025
CDFA: Calibrated deep feature aggregation for screening synergistic drug combinations
doi 10.3389/fphar.2025.1608832
- 987 views
CLINICAL TRIAL
Published on 10 Jun 2025
Clinical outcomes of DNA-damaging agents and DNA damage response inhibitors combinations in cancer: a data-driven review
doi 10.3389/fonc.2025.1577468
- 2,162 views
MINI REVIEW
Published on 05 Jun 2025
Chemotherapy-induced immunogenic cell death in combination with ICIs: a brief review of mechanisms, clinical insights, and therapeutic implications
doi 10.3389/fphar.2025.1572195
- 2,509 views
- 4 citations
ORIGINAL RESEARCH
Published on 30 May 2025
Real-world analysis of immunochemotherapy in recurrent small-cell lung cancer: opportunities for second-line approaches
doi 10.3389/fphar.2025.1591643
- 2,009 views
ORIGINAL RESEARCH
Published on 19 May 2025
Iodine-131 induces ferroptosis and synergizes with sulfasalazine in differentiated thyroid cancer cells via suppressing SLC7A11
doi 10.3389/fonc.2025.1580828
- 1,823 views
REVIEW
Published on 30 Apr 2025
Nanotechnology-driven strategies in postoperative cancer treatment: innovations in drug delivery systems
doi 10.3389/fphar.2025.1586948
- 1,985 views
- 1 citation
ORIGINAL RESEARCH
Published on 17 Apr 2025
Targeting PCNA/PARP1 axis inhibits the malignant progression of hepatocellular carcinoma
doi 10.3389/fphar.2025.1571786
- 2,048 views
- 1 citation
ORIGINAL RESEARCH
Published on 27 Mar 2025
Enhancing survival outcomes in unresectable hepatocellular carcinoma: a prospective cohort study on the effects of Huaier granules with targeted therapy plus immunotherapy
doi 10.3389/fphar.2025.1529010
- 1,718 views
- 2 citations
Published in
Frontiers in Pharmacology
Pharmacology of Anti-Cancer Drugs
Other participating journals
Frontiers in Oncology
- 3.3 impact factor
- 6.9 citescore